{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:51:56Z","timestamp":1784328716979,"version":"3.55.0"},"reference-count":42,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPR"],"DOI":"10.2147\/jpr.s340968","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T20:50:08Z","timestamp":1643748608000},"page":"267-286","source":"Crossref","is-referenced-by-count":21,"title":["Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry"],"prefix":"10.2147","volume":"Volume 15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-9492","authenticated-orcid":true,"given":"Michael A","family":"Ueberall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Essner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vila Silv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard HH","family":"Mueller-Schwefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2058738419838383","DOI":"10.1177\/2058738419838383","volume":"33","author":"Cavalli","year":"2019","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"Van Hecke","year":"2014","journal-title":"Pain"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.pain.2011.09.014","volume":"152","author":"Attal","year":"2011","journal-title":"Pain"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.mayocp.2015.01.018","volume":"90","author":"Gilron","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42466-020-00063-3","volume":"2","author":"Schlereth","year":"2020","journal-title":"Neurol Res Pract"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","volume":"9","author":"Vu\u010dkovi\u0107","year":"2018","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/j.pain.0000000000002269","volume":"162","author":"Soliman","year":"2021","journal-title":"Pain"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/npp.2017.204","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.3390\/ijms21228870","volume":"21","author":"Mlost","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","volume":"66","author":"Russo","year":"2006","journal-title":"Med Hypotheses"},{"key":"ref14","unstructured":"emc. Sativex oromucosal spray. summary of product characteristics; 2020. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/602\/smpc#gref. Accessed April 26, 2021."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","volume":"112","author":"Berman","year":"2004","journal-title":"Pain"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","volume":"133","author":"Nurmikko","year":"2007","journal-title":"Pain"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00415-012-6739-4","volume":"260","author":"Langford","year":"2013","journal-title":"J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/j.1532-2149.2013.00445.x","volume":"18","author":"Serpell","year":"2014","journal-title":"Eur J Pain"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.2147\/JPR.S192174","volume":"12","author":"Ueberall","year":"2019","journal-title":"J Pain Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/pm\/pnab050","volume":"22","author":"Dykukha","year":"2021","journal-title":"Pain Med"},{"key":"ref22","unstructured":"Marinol (dronabinol) prescribing information; 2017. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/018651s029lbl.pdf. Accessed April 26, 2021."},{"key":"ref23","unstructured":"Syndros (dronabinol) prescribing information; 2016. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/205525s000lbl.pdf. Accessed April 26, 2021."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ejp.1147","volume":"22","author":"Krcevski-Skvarc","year":"2018","journal-title":"Eur J Pain"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.38149.566979","volume":"329","author":"Svendsen","year":"2004","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000481089","volume":"78","author":"Schimrigk","year":"2017","journal-title":"Eur Neurol"},{"key":"ref27","unstructured":"Gesetz zur \u00c4nderung bet\u00e4ubungsmittelrechtlicher und anderer Vorschriften [Law amending narcotics law and other regulations]. Bundesgesetzblatt; 2017. Available from: https:\/\/www.bgbl.de\/xaver\/bgbl\/start.xav?start=%2F%2F*%5B%40attr_id%3D%27bgbl117s0403.pdf%27%5D#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl117s0403.pdf%27%5D__1537108060099. Accessed April 30, 2021."},{"key":"ref28","unstructured":"Lips J, Witt J. Cannabis law and legislation in Germany; 2021. Available from: https:\/\/cms.law\/en\/int\/expert-guides\/cms-expert-guide-to-A-legal-roadmap-to-cannabis\/germany. Accessed September 2, 2021."},{"key":"ref29","unstructured":"Deutsche Gesellschaft f\u00fcr Schmerzmedizin e.V. Dokumentationsplattform iDocLive\u00ae.[German Society for Pain Medicine registered association documentationplatform iDocLive\u00ae]. Available from: https:\/\/www.dgschmerzmedizin.de\/. Accessed April 30, 2021."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00482-002-0162-1","volume":"16","author":"Nagel","year":"2002","journal-title":"Schmerz"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0304-3959(92)90154-4","volume":"50","author":"von Korff","year":"1992","journal-title":"Pain"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/00004479-200401000-00012","volume":"27","author":"Kazis","year":"2004","journal-title":"J Ambul Care Manage"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s004829900047","volume":"13","author":"Basler","year":"1999","journal-title":"Schmerz"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-u","volume":"33","author":"Lovibond","year":"1995","journal-title":"Behav Res Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/030079906X132488","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2147\/CEOR.S68997","volume":"6","author":"Cappelleri","year":"2014","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fnins.2018.00502","volume":"12","author":"Bitencourt","year":"2018","journal-title":"Front Neurosci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1089\/acm.2018.0437","volume":"25","author":"Elms","year":"2019","journal-title":"J Altern Complement Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fpsyt.2013.00130","volume":"4","author":"Niesink","year":"2013","journal-title":"Front Psychiatry"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/npp.2017.209","volume":"43","author":"Boggs","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Pain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78010","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78010","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T20:50:12Z","timestamp":1643748612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/comparison-of-the-effectiveness-and-tolerability-of-nabiximols-thccbd--peer-reviewed-fulltext-article-JPR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":42,"URL":"https:\/\/doi.org\/10.2147\/jpr.s340968","relation":{},"ISSN":["1178-7090"],"issn-type":[{"value":"1178-7090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}